Article Details
Retrieved on: 2018-03-12 05:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Aqr Capital Management</b> Llc holds 0% or 25,599 shares in its portfolio. Analysts await Cytokinetics, Incorporated (NASDAQ:CYTK) to report earnings on April, 26. They expect $-0.18 earnings per share, up 70.97% or $0.44 from last year's $-0.62 per share. After $-0.75 actual earnings per share reported ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here